nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP3A4—Temozolomide—malignant glioma	0.0308	1	CbGbCtD
Tolterodine—Influenza-like symptoms—Temozolomide—malignant glioma	0.0193	0.0494	CcSEcCtD
Tolterodine—Memory impairment—Temozolomide—malignant glioma	0.0176	0.045	CcSEcCtD
Tolterodine—Influenza like illness—Temozolomide—malignant glioma	0.0134	0.0343	CcSEcCtD
Tolterodine—Dry eye—Temozolomide—malignant glioma	0.0127	0.0326	CcSEcCtD
Tolterodine—Abnormal vision—Carmustine—malignant glioma	0.0124	0.0319	CcSEcCtD
Tolterodine—Abnormal vision—Temozolomide—malignant glioma	0.012	0.0308	CcSEcCtD
Tolterodine—Dry skin—Temozolomide—malignant glioma	0.00918	0.0235	CcSEcCtD
Tolterodine—Bronchitis—Temozolomide—malignant glioma	0.00832	0.0213	CcSEcCtD
Tolterodine—Dysuria—Temozolomide—malignant glioma	0.00809	0.0207	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00804	0.0206	CcSEcCtD
Tolterodine—Weight increased—Temozolomide—malignant glioma	0.00788	0.0202	CcSEcCtD
Tolterodine—Urinary tract infection—Carmustine—malignant glioma	0.00776	0.0199	CcSEcCtD
Tolterodine—Urinary tract infection—Temozolomide—malignant glioma	0.0075	0.0192	CcSEcCtD
Tolterodine—Sinusitis—Temozolomide—malignant glioma	0.00724	0.0185	CcSEcCtD
Tolterodine—Hallucination—Carmustine—malignant glioma	0.00713	0.0183	CcSEcCtD
Tolterodine—Oedema peripheral—Carmustine—malignant glioma	0.00706	0.0181	CcSEcCtD
Tolterodine—Visual impairment—Carmustine—malignant glioma	0.00691	0.0177	CcSEcCtD
Tolterodine—Hallucination—Temozolomide—malignant glioma	0.00689	0.0176	CcSEcCtD
Tolterodine—Oedema peripheral—Temozolomide—malignant glioma	0.00682	0.0175	CcSEcCtD
Tolterodine—Visual impairment—Temozolomide—malignant glioma	0.00667	0.0171	CcSEcCtD
Tolterodine—Flushing—Carmustine—malignant glioma	0.00665	0.017	CcSEcCtD
Tolterodine—Flushing—Temozolomide—malignant glioma	0.00643	0.0165	CcSEcCtD
Tolterodine—Angioedema—Temozolomide—malignant glioma	0.00551	0.0141	CcSEcCtD
Tolterodine—Vertigo—Temozolomide—malignant glioma	0.00542	0.0139	CcSEcCtD
Tolterodine—Palpitations—Temozolomide—malignant glioma	0.00533	0.0136	CcSEcCtD
Tolterodine—Chest pain—Carmustine—malignant glioma	0.00531	0.0136	CcSEcCtD
Tolterodine—Anxiety—Carmustine—malignant glioma	0.00529	0.0136	CcSEcCtD
Tolterodine—Confusional state—Carmustine—malignant glioma	0.00513	0.0131	CcSEcCtD
Tolterodine—Arthralgia—Temozolomide—malignant glioma	0.00513	0.0131	CcSEcCtD
Tolterodine—Brompheniramine—CYP2B6—malignant glioma	0.00513	0.316	CrCbGaD
Tolterodine—Anxiety—Temozolomide—malignant glioma	0.00512	0.0131	CcSEcCtD
Tolterodine—Oedema—Carmustine—malignant glioma	0.00509	0.013	CcSEcCtD
Tolterodine—Infection—Carmustine—malignant glioma	0.00506	0.013	CcSEcCtD
Tolterodine—Dry mouth—Temozolomide—malignant glioma	0.00502	0.0129	CcSEcCtD
Tolterodine—Tachycardia—Carmustine—malignant glioma	0.00497	0.0127	CcSEcCtD
Tolterodine—Confusional state—Temozolomide—malignant glioma	0.00496	0.0127	CcSEcCtD
Tolterodine—Anaphylactic shock—Temozolomide—malignant glioma	0.00492	0.0126	CcSEcCtD
Tolterodine—Oedema—Temozolomide—malignant glioma	0.00492	0.0126	CcSEcCtD
Tolterodine—Infection—Temozolomide—malignant glioma	0.00489	0.0125	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00464	0.0119	CcSEcCtD
Tolterodine—Somnolence—Carmustine—malignant glioma	0.00453	0.0116	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00448	0.0115	CcSEcCtD
Tolterodine—Somnolence—Temozolomide—malignant glioma	0.00437	0.0112	CcSEcCtD
Tolterodine—Pain—Carmustine—malignant glioma	0.00435	0.0112	CcSEcCtD
Tolterodine—Constipation—Carmustine—malignant glioma	0.00435	0.0112	CcSEcCtD
Tolterodine—Dyspepsia—Temozolomide—malignant glioma	0.00433	0.0111	CcSEcCtD
Tolterodine—Chlorphenamine—SLC6A3—malignant glioma	0.00429	0.264	CrCbGaD
Tolterodine—Fatigue—Temozolomide—malignant glioma	0.00424	0.0109	CcSEcCtD
Tolterodine—Constipation—Temozolomide—malignant glioma	0.00421	0.0108	CcSEcCtD
Tolterodine—Pain—Temozolomide—malignant glioma	0.00421	0.0108	CcSEcCtD
Tolterodine—Feeling abnormal—Carmustine—malignant glioma	0.0042	0.0107	CcSEcCtD
Tolterodine—Gastrointestinal pain—Carmustine—malignant glioma	0.00416	0.0107	CcSEcCtD
Tolterodine—Feeling abnormal—Temozolomide—malignant glioma	0.00406	0.0104	CcSEcCtD
Tolterodine—Abdominal pain—Carmustine—malignant glioma	0.00403	0.0103	CcSEcCtD
Tolterodine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00402	0.0103	CcSEcCtD
Tolterodine—Abdominal pain—Temozolomide—malignant glioma	0.00389	0.00996	CcSEcCtD
Tolterodine—Hypersensitivity—Carmustine—malignant glioma	0.00375	0.00961	CcSEcCtD
Tolterodine—Asthenia—Carmustine—malignant glioma	0.00365	0.00936	CcSEcCtD
Tolterodine—Hypersensitivity—Temozolomide—malignant glioma	0.00363	0.00928	CcSEcCtD
Tolterodine—Atomoxetine—SLC6A3—malignant glioma	0.00361	0.222	CrCbGaD
Tolterodine—Asthenia—Temozolomide—malignant glioma	0.00353	0.00904	CcSEcCtD
Tolterodine—Diarrhoea—Carmustine—malignant glioma	0.00348	0.00892	CcSEcCtD
Tolterodine—Dizziness—Carmustine—malignant glioma	0.00337	0.00862	CcSEcCtD
Tolterodine—Diarrhoea—Temozolomide—malignant glioma	0.00337	0.00862	CcSEcCtD
Tolterodine—Dizziness—Temozolomide—malignant glioma	0.00325	0.00833	CcSEcCtD
Tolterodine—Orphenadrine—CYP2B6—malignant glioma	0.00323	0.199	CrCbGaD
Tolterodine—Headache—Carmustine—malignant glioma	0.00319	0.00817	CcSEcCtD
Tolterodine—Headache—Temozolomide—malignant glioma	0.00308	0.00789	CcSEcCtD
Tolterodine—CHRM4—Signaling by GPCR—KRAS—malignant glioma	9.01e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	8.98e-05	0.00016	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SPP1—malignant glioma	8.83e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	8.81e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—FGF2—malignant glioma	8.81e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SPP1—malignant glioma	8.81e-05	0.000157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	8.8e-05	0.000156	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SPHK1—malignant glioma	8.77e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	8.77e-05	0.000156	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	8.73e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SPP1—malignant glioma	8.72e-05	0.000155	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	8.68e-05	0.000154	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—KRAS—malignant glioma	8.63e-05	0.000153	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.6e-05	0.000153	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.58e-05	0.000153	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.5e-05	0.000151	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—FGF2—malignant glioma	8.44e-05	0.00015	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CG—malignant glioma	8.41e-05	0.00015	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL2—malignant glioma	8.41e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL2—malignant glioma	8.38e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TERT—malignant glioma	8.37e-05	0.000149	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TERT—malignant glioma	8.35e-05	0.000148	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL2—malignant glioma	8.3e-05	0.000148	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PIK3CA—malignant glioma	8.27e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TERT—malignant glioma	8.27e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MDM2—malignant glioma	8.24e-05	0.000147	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RAF1—malignant glioma	8.21e-05	0.000146	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PDGFB—malignant glioma	8.17e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PDGFB—malignant glioma	8.15e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGFR1—malignant glioma	8.13e-05	0.000145	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.13e-05	0.000145	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ERBB2—malignant glioma	8.13e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PPARG—malignant glioma	8.12e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGFR1—malignant glioma	8.11e-05	0.000144	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	8.07e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	8.03e-05	0.000143	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CB—malignant glioma	8.02e-05	0.000143	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GSTP1—malignant glioma	8.01e-05	0.000142	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HIF1A—malignant glioma	8.01e-05	0.000142	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HIF1A—malignant glioma	7.98e-05	0.000142	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	7.92e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	7.91e-05	0.000141	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MDM2—malignant glioma	7.89e-05	0.00014	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RAF1—malignant glioma	7.87e-05	0.00014	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAT—malignant glioma	7.8e-05	0.000139	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ERBB2—malignant glioma	7.78e-05	0.000138	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CAV1—malignant glioma	7.75e-05	0.000138	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CAV1—malignant glioma	7.72e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CXCL8—malignant glioma	7.71e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	7.68e-05	0.000137	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KDR—malignant glioma	7.66e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.65e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KDR—malignant glioma	7.64e-05	0.000136	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KDR—malignant glioma	7.56e-05	0.000134	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AKT1—malignant glioma	7.44e-05	0.000132	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.41e-05	0.000132	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CD—malignant glioma	7.39e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CXCL8—malignant glioma	7.38e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—malignant glioma	7.38e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—F2—malignant glioma	7.37e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FN1—malignant glioma	7.37e-05	0.000131	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GSTP1—malignant glioma	7.37e-05	0.000131	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—NCOR1—malignant glioma	7.36e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL2—malignant glioma	7.36e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—F2—malignant glioma	7.35e-05	0.000131	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FN1—malignant glioma	7.35e-05	0.000131	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GSTP1—malignant glioma	7.31e-05	0.00013	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BAD—malignant glioma	7.29e-05	0.00013	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—F2—malignant glioma	7.28e-05	0.000129	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FN1—malignant glioma	7.28e-05	0.000129	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BAD—malignant glioma	7.26e-05	0.000129	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	7.22e-05	0.000128	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	7.19e-05	0.000128	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BAD—malignant glioma	7.19e-05	0.000128	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAT—malignant glioma	7.17e-05	0.000128	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	7.13e-05	0.000127	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	7.12e-05	0.000127	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAT—malignant glioma	7.11e-05	0.000126	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CD80—malignant glioma	7.07e-05	0.000126	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—malignant glioma	7.06e-05	0.000126	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APC—malignant glioma	7.06e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	7.06e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL2—malignant glioma	7.05e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CD80—malignant glioma	7.05e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APC—malignant glioma	7.03e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	7.03e-05	0.000125	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CD80—malignant glioma	6.98e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGF—malignant glioma	6.97e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—malignant glioma	6.97e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APC—malignant glioma	6.97e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	6.97e-05	0.000124	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTT1—malignant glioma	6.95e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGF—malignant glioma	6.95e-05	0.000124	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	6.93e-05	0.000123	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTEN—malignant glioma	6.93e-05	0.000123	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTPN11—malignant glioma	6.91e-05	0.000123	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGF—malignant glioma	6.89e-05	0.000122	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	6.84e-05	0.000122	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.77e-05	0.00012	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—malignant glioma	6.76e-05	0.00012	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—NCOR1—malignant glioma	6.72e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—malignant glioma	6.67e-05	0.000119	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTEN—malignant glioma	6.64e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BRAF—malignant glioma	6.63e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BRAF—malignant glioma	6.61e-05	0.000118	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.55e-05	0.000116	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS1—malignant glioma	6.52e-05	0.000116	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—malignant glioma	6.47e-05	0.000115	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT2—malignant glioma	6.46e-05	0.000115	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CB—malignant glioma	6.45e-05	0.000115	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT2—malignant glioma	6.44e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	6.43e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EGFR—malignant glioma	6.41e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—malignant glioma	6.39e-05	0.000114	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.37e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	6.35e-05	0.000113	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—malignant glioma	6.26e-05	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	6.2e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—STAT3—malignant glioma	6.2e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	6.18e-05	0.00011	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	6.14e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	6.12e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	6.12e-05	0.000109	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	6.07e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	6.07e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—BCHE—malignant glioma	6.06e-05	0.000108	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—KRAS—malignant glioma	6.05e-05	0.000108	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAV1—malignant glioma	6e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.99e-05	0.000107	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—malignant glioma	5.99e-05	0.000107	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.98e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGF2—malignant glioma	5.94e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—STAT3—malignant glioma	5.93e-05	0.000106	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGF2—malignant glioma	5.92e-05	0.000105	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.86e-05	0.000104	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MYC—malignant glioma	5.76e-05	0.000102	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.74e-05	0.000102	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGFR—malignant glioma	5.63e-05	0.0001	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	5.58e-05	9.92e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTEN—malignant glioma	5.57e-05	9.9e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	5.56e-05	9.89e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MDM2—malignant glioma	5.56e-05	9.88e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MDM2—malignant glioma	5.54e-05	9.85e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RAF1—malignant glioma	5.54e-05	9.85e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAV1—malignant glioma	5.52e-05	9.82e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RAF1—malignant glioma	5.52e-05	9.81e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—malignant glioma	5.51e-05	9.8e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.51e-05	9.79e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.49e-05	9.75e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	5.48e-05	9.74e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAV1—malignant glioma	5.47e-05	9.73e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.47e-05	9.72e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.47e-05	9.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	5.46e-05	9.71e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.41e-05	9.62e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	5.41e-05	9.61e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGFR—malignant glioma	5.39e-05	9.59e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	5.39e-05	9.58e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.34e-05	9.49e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—KRAS—malignant glioma	5.32e-05	9.46e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PPARG—malignant glioma	5.28e-05	9.38e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.23e-05	9.3e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	5.2e-05	9.24e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	5.18e-05	9.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	5.13e-05	9.12e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—KRAS—malignant glioma	5.1e-05	9.06e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.03e-05	8.94e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	5.02e-05	8.92e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	5e-05	8.9e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.99e-05	8.86e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—malignant glioma	4.97e-05	8.84e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL2—malignant glioma	4.97e-05	8.83e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—malignant glioma	4.96e-05	8.81e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.95e-05	8.81e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL2—malignant glioma	4.95e-05	8.8e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.91e-05	8.73e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL2—malignant glioma	4.9e-05	8.71e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	4.89e-05	8.69e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PPARG—malignant glioma	4.85e-05	8.63e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.82e-05	8.57e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PPARG—malignant glioma	4.81e-05	8.56e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.81e-05	8.55e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—malignant glioma	4.73e-05	8.41e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—malignant glioma	4.7e-05	8.36e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAT—malignant glioma	4.69e-05	8.34e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—malignant glioma	4.68e-05	8.33e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	4.68e-05	8.32e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTEN—malignant glioma	4.67e-05	8.31e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTEN—malignant glioma	4.66e-05	8.28e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.64e-05	8.25e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.61e-05	8.2e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	4.56e-05	8.1e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	4.54e-05	8.08e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—malignant glioma	4.53e-05	8.05e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.5e-05	8e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.43e-05	7.87e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.42e-05	7.86e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.38e-05	7.79e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	4.22e-05	7.5e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	4.21e-05	7.48e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.19e-05	7.45e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—STAT3—malignant glioma	4.18e-05	7.43e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	4.17e-05	7.41e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—STAT3—malignant glioma	4.17e-05	7.41e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.15e-05	7.38e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—STAT3—malignant glioma	4.12e-05	7.33e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—malignant glioma	3.99e-05	7.1e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PIK3CA—malignant glioma	3.93e-05	6.99e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—malignant glioma	3.88e-05	6.9e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—malignant glioma	3.87e-05	6.88e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.85e-05	6.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—malignant glioma	3.83e-05	6.81e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—malignant glioma	3.82e-05	6.8e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.82e-05	6.79e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.82e-05	6.79e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGFR—malignant glioma	3.8e-05	6.75e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.79e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGFR—malignant glioma	3.79e-05	6.73e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.75e-05	6.66e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTEN—malignant glioma	3.62e-05	6.44e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAV1—malignant glioma	3.61e-05	6.42e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KRAS—malignant glioma	3.59e-05	6.38e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KRAS—malignant glioma	3.58e-05	6.36e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.54e-05	6.3e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTEN—malignant glioma	3.33e-05	5.92e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTEN—malignant glioma	3.3e-05	5.87e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	3.3e-05	5.86e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.29e-05	5.85e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	3.29e-05	5.84e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.25e-05	5.78e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—malignant glioma	3.21e-05	5.71e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—malignant glioma	3.19e-05	5.67e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—malignant glioma	3.18e-05	5.65e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PPARG—malignant glioma	3.17e-05	5.64e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—malignant glioma	3.15e-05	5.6e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.89e-05	5.14e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.69e-05	4.79e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—malignant glioma	2.68e-05	4.77e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.66e-05	4.73e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.55e-05	4.54e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.52e-05	4.48e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.5e-05	4.44e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.35e-05	4.18e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.33e-05	4.14e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTEN—malignant glioma	2.18e-05	3.87e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—malignant glioma	2.09e-05	3.71e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—malignant glioma	1.92e-05	3.41e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—malignant glioma	1.9e-05	3.38e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.54e-05	2.73e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—malignant glioma	1.25e-05	2.23e-05	CbGpPWpGaD
